BioGaia has signed a 5-year agreement with J Health Enterprise Ltd giving the company exclusive rights to distribute Reuteri tablets in Hong Kong
The company is well established in the largest chain for health and beauty products, Watsons, with 150 outlets in Hong Kong. J Health will also sell through physicians and via hospitals. The company has approximately 40 sales staff and today works only with products from Japan. The launch of Reuteri tablets will represent the first European product in their portfolio. Sales of Reuteri tablets are expected to start during autumn 2005.
This agreement is an important stepping-stone to a later entry into the gigantic Chinese market. "There is a great need for products specifically targeted for children's health in both Hong Kong and China." says Peter Rothschild MD, BioGaia AB
"This contract shows that our investment in personnel locally in Asia begins to pay off. We have had our own staff in Hong Kong since the middle of last year and see now how this presence shortens the business process and time to market dramatically compared with dealing with distant markets from Sweden." concludes Rothschild.